Cardinal Health Financial Statements (CAH)
|
|
|
|
Report date
|
|
|
13.08.2020 |
16.08.2021 |
11.08.2022 |
15.08.2023 |
14.08.2024 |
|
01.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
152 922 |
162 467 |
181 364 |
205 012 |
226 827 |
|
224 500 |
|
Operating Income, bln rub |
|
|
1 773 |
1 841 |
1 648 |
727.0 |
1 243 |
|
2 183 |
|
EBITDA, bln rub |
? |
|
-2 617 |
1 310 |
126.0 |
1 441 |
1 978 |
|
2 572 |
|
Net profit, bln rub |
? |
|
-3 693 |
611.0 |
-932.0 |
261.0 |
852.0 |
|
1 263 |
|
|
OCF, bln rub |
? |
|
1 960 |
2 429 |
3 122 |
2 839 |
3 762 |
|
1 570 |
|
CAPEX, bln rub |
? |
|
375.0 |
400.0 |
387.0 |
481.0 |
511.0 |
|
509.0 |
|
FCF, bln rub |
? |
|
1 585 |
2 029 |
2 735 |
2 358 |
3 251 |
|
1 061 |
|
Dividend payout, bln rub
|
|
|
569.0 |
573.0 |
559.0 |
525.0 |
499.0 |
|
496.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
93.8% |
0.00% |
201.1% |
58.6% |
|
39.3% |
|
|
OPEX, bln rub |
|
|
5 096 |
4 984 |
4 881 |
5 119 |
5 000 |
|
5 182 |
|
Cost of production, bln rub |
|
|
146 054 |
155 689 |
174 819 |
198 123 |
219 413 |
|
217 060 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
238.0 |
180.0 |
149.0 |
93.0 |
51.0 |
|
73.0 |
|
|
Assets, bln rub |
|
|
40 766 |
44 453 |
43 878 |
43 417 |
45 121 |
|
43 059 |
|
Net Assets, bln rub |
? |
|
1 792 |
1 794 |
-706.0 |
-2 851 |
-3 213 |
|
-3 277 |
|
Debt, bln rub |
|
|
6 775 |
6 236 |
5 315 |
4 701 |
5 092 |
|
5 164 |
|
Cash, bln rub |
|
|
2 771 |
3 407 |
4 717 |
4 043 |
5 133 |
|
2 867 |
|
Net debt, bln rub |
|
|
4 004 |
2 829 |
598.0 |
658.0 |
-41.0 |
|
2 297 |
|
|
Ordinary share price, rub |
|
|
52.2 |
57.1 |
52.3 |
94.6 |
98.3 |
|
93.8 |
|
Number of ordinary shares, mln |
|
|
293.0 |
292.0 |
279.0 |
261.0 |
245.0 |
|
243.0 |
|
|
Market cap, bln rub |
|
|
15 292 |
16 670 |
14 583 |
24 683 |
24 088 |
|
22 791 |
|
EV, bln rub |
? |
|
19 296 |
19 499 |
15 181 |
25 341 |
24 047 |
|
25 088 |
|
Book value, bln rub |
|
|
-9 483 |
-8 300 |
-8 335 |
-8 932 |
-9 663 |
|
-9 665 |
|
|
EPS, rub |
? |
|
-12.6 |
2.09 |
-3.34 |
1.00 |
3.48 |
|
5.20 |
|
FCF/share, rub |
|
|
5.41 |
6.95 |
9.80 |
9.03 |
13.3 |
|
4.37 |
|
BV/share, rub |
|
|
-32.4 |
-28.4 |
-29.9 |
-34.2 |
-39.4 |
|
-39.8 |
|
|
EBITDA margin, % |
? |
|
-1.71% |
0.81% |
0.07% |
0.70% |
0.87% |
|
1.15% |
|
Net margin, % |
? |
|
-2.41% |
0.38% |
-0.51% |
0.13% |
0.38% |
|
0.56% |
|
FCF yield, % |
? |
|
10.4% |
12.2% |
18.8% |
9.55% |
13.5% |
|
4.66% |
|
ROE, % |
? |
|
-206.1% |
34.1% |
132.0% |
-9.15% |
-26.5% |
|
-38.5% |
|
ROA, % |
? |
|
-9.06% |
1.37% |
-2.12% |
0.60% |
1.89% |
|
2.93% |
|
|
P/E |
? |
|
-4.14 |
27.3 |
-15.6 |
94.6 |
28.3 |
|
18.0 |
|
P/FCF |
|
|
9.65 |
8.22 |
5.33 |
10.5 |
7.41 |
|
21.5 |
|
P/S |
? |
|
0.10 |
0.10 |
0.08 |
0.12 |
0.11 |
|
0.10 |
|
P/BV |
? |
|
-1.61 |
-2.01 |
-1.75 |
-2.76 |
-2.49 |
|
-2.36 |
|
EV/EBITDA |
? |
|
-7.37 |
14.9 |
120.5 |
17.6 |
12.2 |
|
9.75 |
|
Debt/EBITDA |
|
|
-1.53 |
2.16 |
4.75 |
0.46 |
-0.02 |
|
0.89 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.25% |
0.25% |
0.21% |
0.23% |
0.23% |
|
0.23% |
|
| Cardinal Health shareholders |
